Lightning Talk and Exhibitor Opportunity, Organized by MIT Media Lab with contributions from MIT Startup Exchange and Takeda Pharmaceuticals
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
Bringing the Power of Medicinal Chemistry to Protein Therapies
A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.
Startup Lightning Talks
MIT STARTUP EXCHANGE JUNE 2024 DEMO DAY
June 6, 2024
Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.